Description
Transdermal Peptide TD-1 Amide is novel peptide designed to enhance transdermal drug delivery. Mechanistic studies suggest that the peptide creates transient opening in the skin barrier, which enables protein-sized molecules to pass through the skin and reach systemic circulation. When TD-1 is co-administrated with insulin on rat skin, systemic levels of insulin and human growth hormone are increased significantly.
SEQUENCE: H-Ala-Cys-Ser-Ser-Ser-Pro-Ser-Lys-His-Cys-Gly-NH2 (disulfide bridge)
ONE-LETTER SEQUENCE: ACSSSPSKHCG-NH2 (disulfide bridge)
MOLECULAR FORMULA: C40H67N15O15S2
MOLECULAR WEIGHT: 1060.17
STORAGE CONDITIONS: -20 ± 5 °C
CAS REGISTRY NUMBER:
SYNONYMS: TD-1
RESEARCH AREA: Miscellaneous
REFERENCES:
Chen, Y. et al. Nat. Biotechnol. 24, 455 (2006)
SKU(s): MISC-016A, MISC-016B, MISC-016C
KEYWORDS: peptide macrocycle
Additional information
| Size | |
|---|---|
| Research Area | |
| Distributor Pricing |

